Yi Xiang Zhou
Director/Board Member at Shanghai Xinchuan Investment Management Co. Ltd.
Profile
Yi Xiang Zhou is currently a Member-Supervisory Board at Shanghai Xinchuan Investment Management Co. Ltd.
Previously, he held the same position at Canature Health Technology Group Co., Ltd.
He completed his undergraduate degree at Shanghai Open University.
Yi Xiang Zhou active positions
Companies | Position | Start |
---|---|---|
Shanghai Xinchuan Investment Management Co. Ltd.
Shanghai Xinchuan Investment Management Co. Ltd. Financial ConglomeratesFinance Part of Shanghai Origincell Biological Cryo Equipment Co. Ltd., Shanghai Xinchuan Investment Management Co. Ltd. provides investment and investment management services. The company is based in Shanghai, China. Shanghai Xinchuan Investment Management Co. was founded in 2011. Shanghai Xinchuan Investment Management Co. was acquired by Lishui Yuanxin Industry Development Co. Ltd. from Canature Health Technology Group Co., Ltd. on December 28, 2021 for $27.42 million. | Director/Board Member | - |
Former positions of Yi Xiang Zhou
Companies | Position | End |
---|---|---|
CANATURE HEALTH TECHNOLOGY CO., LTD. | Director/Board Member | - |
Training of Yi Xiang Zhou
Shanghai Open University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
CANATURE HEALTH TECHNOLOGY CO., LTD. | Producer Manufacturing |
Private companies | 1 |
---|---|
Shanghai Xinchuan Investment Management Co. Ltd.
Shanghai Xinchuan Investment Management Co. Ltd. Financial ConglomeratesFinance Part of Shanghai Origincell Biological Cryo Equipment Co. Ltd., Shanghai Xinchuan Investment Management Co. Ltd. provides investment and investment management services. The company is based in Shanghai, China. Shanghai Xinchuan Investment Management Co. was founded in 2011. Shanghai Xinchuan Investment Management Co. was acquired by Lishui Yuanxin Industry Development Co. Ltd. from Canature Health Technology Group Co., Ltd. on December 28, 2021 for $27.42 million. | Finance |
- Stock Market
- Insiders
- Yi Xiang Zhou